Current state and prospects of using dendritic cell vaccination for cancer immunotherapy by I.Yu. Filin, K.V. Kitaeva, A.A. Rizvanov, V.V. Solovyeva

Subjects: Get full text

Livestock Vaccines: Principles, Types, and Important Factors to Consider by Juan M. Campos Krauer, João H. J. Bittar

Subjects: “…vaccines…”
Get full text

Marburg virus reaches Rwanda: how close are we to a vaccine solution? by Olivier Sibomana, Clyde Moono Hakayuwa, Jildas Munyantore

Subjects: Get full text

Innovation for Making Portable Induction Furniture as a Solution for System Waste Handling Post-vaccination COVID-19 Vaccine by Ridwan Abdurrahman, Ahmad Kafrawi Nasution, Ayub Satria

Get full text

Factors associated with vaccine default in Southern Ghana based on data from the RTSS malaria vaccine trial in Cape Coast by Vincent Bio Bediako, Josephine Akua Ackah, Theophilus Junior Yankey, Joshua Okyere, Emmanuella Acheampong, Bernard Afriyie Owusu, Wonder Agbemavi, Adanna Uloaku Nwameme, Edward Mberu Kamau, Emmanuel Asampong

Subjects: Get full text

Adherence to vaccination against SARS-CoV-2 and vaccine safety in patients with immunoglobulin G4-related disease by Linda Mastromanno, Federico Giardina, Angelica Gattamelata, Serena Colafrancesco, Simona Truglia, Francesca Romana Spinelli, Edoardo Simoncelli, Bruno Lucchino, Fabrizio Conti, Roberta Priori

Subjects: Get full text

Prevalence of non-vaccine high-risk HPV cervical infections in vaccinated women: a systematic review and meta-analysis by Glauciane Resende do Nascimento, Ana Carolina da Silva Santos, Nayara Nascimento Toledo Silva, Nathalia Sernizon Guilmarães, Angélica Alves Lima, Wendel Coura-Vital

Subjects: Get full text

Improved population coverage of the human papillomavirus vaccine after implementation of a school-based vaccination programme: the Singapore experience by Karuppiah Vijayalakshmi, Anne Hui Yi Goei

“…Despite constant efforts to encourage vaccination, local HPV vaccine uptake remains low. Universal mass vaccination is a proven cost-effective method to reduce the cervical cancer disease burden. …”
Get full text

Evaluation of the adherence of municipalities and states to the Ministry of Health’s microplanning for high-quality vaccination activities and the increase in vaccination coverage in Brazil by Ana Catarina de Melo Araújo, Thales Philipe Rodrigues da Silva, Gustavo Velasquez-Melendez, Luciana Maiara Diogo Nascimento, Carla Conceição Ferraz, Fernanda Penido Matozinhos, Eder Gatti Fernandes

Subjects: “…Vaccination…”
Get full text

A novel platform for engineered AAV-based vaccines by Sabrina Babutzka, Miranda Gehrke, Anastasia Papadopoulou, Maria Diedrichs-Möhring, Maria Giannaki, Lena Hennis, Bastian Föhr, Cale Kooyman, Andreas Osterman, Evangelia Yannaki, Gerhild Wildner, Hermann Ammer, Stylianos Michalakis

Subjects: Get full text

Tuberculosis vaccines and therapeutic drug: challenges and future directions by Yajing An, Ruizi Ni, Li Zhuang, Ling Yang, Zhaoyang Ye, Linsheng Li, Seppo Parkkila, Ashok Aspatwar, Wenping Gong

“…The hurdles in TB vaccine and therapeutic development encompass overcoming antigen diversity, enhancing vaccine effectiveness across diverse populations, and advancing novel vaccine platforms. …”
Get full text

Hepatitis a Vaccines: How will We Use Them? by Gilles Delage

Get full text

Production and development of vaccines for ornithobacterium rhinotracheale infection in turkeys by Osman Erganis, Hasan Hüseyin Hadimli, Kursat Kav, Zafer Sayin, Zeki Aras

Subjects: Get full text

The role of new hepatitis B vaccines in South Africa by G U van Zyl, T Maponga, H Rabie, J Taljaard

Subjects: Get full text

Role of Interferons in the Development of Diagnostics, Vaccines, and Therapy for Tuberculosis by Kai Ling Chin, Fadhilah Zulkipli Anis, Maria E. Sarmiento, Mohd Nor Norazmi, Armando Acosta

Get full text

Antigen Delivery Platforms for Next-Generation Coronavirus Vaccines by Aziz A. Chentoufi, Jeffrey B. Ulmer, Lbachir BenMohamed

Subjects: Get full text

Dendritic Cells as Vaccines: Key Regulators of Tolerance and Immunity by Jurjen Tel, Daniel Benitez-Ribas, Edith M. Janssen, Evelien L. J. Smits, Joannes F. M. Jacobs

Get full text

Patent Dimensions in the Development and Production of COVID-19 Vaccines by Tobias Volpert, Marcel Riepe

“…Abstract The process in which COVID-19 vaccines are developed is sequential and continuously accumulating. …”
Get full text

COVID-19 Booster Vaccines Administration in Different Countries by Angel Yun-Kuan Thye, Loh Teng-Hern Tan, Jodi Woan Fei Law, Vengadesh Letchumanan

“…The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that resulted in the COVID-19 global pandemic had consequently led to the development of different types of COVID-19 vaccines, including the messenger RNA (mRNA) vaccines, inactivated virus vaccines, a protein subunit vaccine, and viral vector recombinant vaccines. …”
Get full text

Updates on the development of vaccines and therapeutic options against rabies by Roshan Arjun Ananda, Hooi-Leng Ser, Vengadesh Letchumanan

“… Even though rabies has been claiming more than 50,000 deaths annually worldwide, it is considered as a vaccine-preventable viral disease. More than 95 % of the total human rabies cases are caused by dogs. …”
Get full text